Tacrolimus

insulin ; Homo sapiens







74 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34854174 Tacrolimus-induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient. 2022 Mar 1
2 35212883 Relation of adipose tissue and skeletal muscle FKBP5 expression with insulin sensitivity and the regulation of FKBP5 by insulin and free fatty acids. 2022 Jun 1
3 35294797 Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus-induced diabetes mellitus and nephrotoxicity in a rat model. 2022 Jun 2
4 31941840 Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable. 2020 Jan 16 2
5 32894758 Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets. 2020 Nov 1 3
6 33202516 Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study. 2020 Dec 2
7 31402251 Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus. 2019 Sep 1
8 31490380 Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literature. 2019 Sep 2
9 29380240 Calcineurin is an important factor involved in glucose uptake in human adipocytes. 2018 Aug 1
10 27458792 Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation. 2017 Jan 1
11 28720321 No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. 2017 Sep 1
12 26735686 Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. 2016 1
13 26849622 Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway. 2016 3
14 25431882 The Effect of Tacrolimus on Reactive Oxygen Species and Total Antioxidant Status in Pancreatic Beta Cell Line. 2015 Dec 2
15 25644968 Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. 2015 May 2
16 24507957 Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment. 2014 Apr 1
17 25255841 Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. 2014 Nov 3
18 23160140 The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. 2013 Jan 30 2
19 24085506 Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. 2013 Nov 1
20 21988494 Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers. 2012 Apr 1
21 22310596 Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. 2012 Jan 1
22 22814600 Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. 2012 Jul 17 1
23 22897149 Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation. 2012 Oct 1
24 23003106 The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients. 2012 Dec 1
25 23018257 Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation. 2012 Jul-Sep 1
26 21471328 No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus. 2011 Nov 1
27 21720672 Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. 2011 Spring 2
28 20145524 Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. 2010 Feb 15 2
29 20199368 Family history of diabetes as a new determinant of insulin sensitivity and secretion in patients who have undergone a simultaneous pancreas-kidney transplant. 2010 Mar 1
30 19134532 Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. 2009 Jan 1
31 19161445 Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. 2009 Apr 1
32 19500470 Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. 2009 2
33 19543067 Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. 2009 Jun 27 1
34 19628039 Tacrolimus causes a blockage of protein secretion which reinforces its immunosuppressive activity and also explains some of its toxic side-effects. 2009 Dec 2
35 18431361 Regulated insulin delivery from human epidermal cells reverses hyperglycemia. 2008 Jun 1
36 18703143 Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation. 2008 Nov 5
37 16549165 The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation. 2006 Mar 1
38 16569741 Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. 2006 Jun 1
39 16680182 Immunosuppression for islet transplantation. 2006 Apr 2
40 15479952 Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. 2005 Feb 5
41 15677500 Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. 2005 Feb 1
42 15919458 Safety analysis after tacrolimus immunosuppression in renal transplant recipients in Japan: 5-year results in >1500 patients. 2005 May 1
43 15932724 [Study of the effects of immunosuppressive agents on human islet cells in vitro]. 2005 Mar 16 2
44 16235347 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. 2005 Oct 19 1
45 16298573 Audit of diabetes in a renal transplant population. 2005 Oct 1
46 15041369 Immunosuppression for pancreatic islet transplantation. 2004 Mar 2
47 15575024 Evaluating mechanisms of post-transplant diabetes mellitus. 2004 Dec 5
48 12644894 Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. 2003 Mar 7
49 12761338 Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. 2003 Jun 5
50 12808614 Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. 2003 Jun 1